BOEHRINGER INGELHEIM INTERNATIONAL GMBH

In News

Boehringer gains exclusive license for novel immune therapies - Boehringer Ingelheim

Boehringer Ingelheim - Feb 26, 2026

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas - Boehringer Ingelheim

Boehringer Ingelheim - Apr 15, 2026

Planning certainty is the foundation for innovation, healthcare delivery and value creation - Boehringer Ingelheim

Boehringer Ingelheim - Jun 09, 2026

2025 pipeline key product launches sales growth - Boehringer Ingelheim

Boehringer Ingelheim - Mar 25, 2026

Our work with the Bill and Melinda Gates Foundation - Boehringer Ingelheim

Boehringer Ingelheim - Apr 04, 2026

View from both sides of human health business development - Boehringer Ingelheim

Boehringer Ingelheim - Dec 19, 2025

New partnership helps advance our cancer ADCs portfolio - Boehringer Ingelheim

Boehringer Ingelheim - Oct 15, 2025

How to improve the patient experience in healthcare - Boehringer Ingelheim

Boehringer Ingelheim - Mar 25, 2026

US FDA approves first-line use of Boehringer Ingelheim's lung cancer drug - Reuters

Reuters - Feb 26, 2026

Quality at Boehringer Ingelheim - Boehringer Ingelheim

Boehringer Ingelheim - Aug 18, 2025

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2 - Boehringer Ingelheim

Boehringer Ingelheim - Jul 28, 2025

Boehringer Ingelheim and NIPER sign MoU on pharmaceutical research - Pharmaceutical Technology

Pharmaceutical Technology - Feb 20, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment